News Stories (1 Result) - Biotechnology
Alector, a clinical-stage biotechnology company pioneering immuno-neurology, entered into a debt financing agreement with Hercules Capital for up to $50 million. Under the terms of the agreement, Alector drew an initial $10 million at closing. An...
Read Story
November 15, 2024, 08:00 AM
|